Amyloid-ß-directed immunotherapy for Alzheimer's disease

Lannfelt L, Relkin NR, Siemers ER (Uppsala University, Uppsala, Sweden; Weill Cornell Medical College, New York, NY; and Eli Lilly and Co., Indianapolis, IN, USA). Amyloid-ß-directed immunotherapy for Alzheimer’s disease. (Key Symposium). J Intern Med 2014; 275: 284–295. Current treatment options fo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Intern Med
Auteurs principaux: Lannfelt, L, Relkin, N R, Siemers, E R
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2014
Sujets:
Key Symposium: Updating Alzheimer's Disease Diagnosis - Implications for Prevention and Treatment
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238820/
https://ncbi.nlm.nih.gov/pubmed/24605809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joim.12168
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires